Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M604728200 on August 23, 2006

J. Biol. Chem., Vol. 281, Issue 42, 31538-31543, October 20, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/42/31538    most recent
M604728200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zeöld, A.
Right arrow Articles by Gereben, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zeöld, A.
Right arrow Articles by Gereben, B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Metabolic Instability of Type 2 Deiodinase Is Transferable To Stable Proteins Independently of Subcellular Localization*

Anikó Zeöld{ddagger}, Lívia Pormüller{ddagger}, Monica Dentice§, John W. Harney§, Cyntia Curcio-Morelli§, Susana M. Tente§, Antonio C. Bianco§, and Balázs Gereben{ddagger}1

From the {ddagger}Laboratory of Endocrine Neurobiology, Institute of Experimental Medicine, Hungarian Academy of Sciences, Szigony Street 43, Budapest H-1083, Hungary and §Thyroid Section, Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital and Harvard University Medical School, Boston, Massachusetts 02115

Thyroid hormone activation is catalyzed by two deiodinases, D1 and D2. Whereas D1 is a stable plasma membrane protein, D2 is resident in the endoplasmic reticulum (ER) and has a 20-min half-life due to selective ubiquitination and proteasomal degradation. Here we have shown that stable retention explains D2 residency in the ER, a mechanism that is nevertheless over-ridden by fusion to the long-lived plasma membrane protein, sodium-iodine symporter. Fusion to D2, but not D1, dramatically shortened sodium-iodine symporter half-life through a mechanism dependent on an 18-amino acid D2-specific instability loop. Similarly, the D2-specific loop-mediated protein destabilization was also observed after D2, but not D1, was fused to the stable ER resident protein SEC62. This indicates that the instability loop in D2, but not its subcellular localization, is the key determinant of D2 susceptibility to ubiquitination and rapid turnover rate. Our data also show that the 6 N-terminal amino acids, but not the 12 C-terminal ones, are the ones required for D2 recognition by WSB-1.


Received for publication, May 17, 2006 , and in revised form, August 21, 2006.

* This work was supported by National Institutes of Health Grants TW006467, DK58538, and DK36246 and by Hungarian Scientific Research Fund Grant OTKA T49081. [GenBank] The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 To whom correspondence should be addressed. Tel.: 36-1-210-9946; Fax: 36-1-210-9961; E-mail: gereben{at}koki.hu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
B. W. Kim and A. C. Bianco
For Some, L-Thyroxine Replacement Might Not Be Enough: A Genetic Rationale
J. Clin. Endocrinol. Metab., May 1, 2009; 94(5): 1521 - 1523.
[Full Text] [PDF]


Home page
Endocr. Rev.Home page
B. Gereben, A. M. Zavacki, S. Ribich, B. W. Kim, S. A. Huang, W. S. Simonides, A. Zeold, and A. C. Bianco
Cellular and Molecular Basis of Deiodinase-Regulated Thyroid Hormone Signaling
Endocr. Rev., December 1, 2008; 29(7): 898 - 938.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
I. Meulenbelt, J. L. Min, S. Bos, N. Riyazi, J. J. Houwing-Duistermaat, H.-J. van der Wijk, H. M. Kroon, M. Nakajima, S. Ikegawa, A. G. Uitterlinden, et al.
Identification of DIO2 as a new susceptibility locus for symptomatic osteoarthritis
Hum. Mol. Genet., June 15, 2008; 17(12): 1867 - 1875.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. W. Choi, Y.-M. Seo, E.-A Kim, K. S. Sung, J. W. Ahn, S.-J. Park, S.-R. Lee, and C. Y. Choi
Ubiquitination and Degradation of Homeodomain-interacting Protein Kinase 2 by WD40 Repeat/SOCS Box Protein WSB-1
J. Biol. Chem., February 22, 2008; 283(8): 4682 - 4689.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Lamirand, G. Mercier, M. Ramauge, M. Pierre, and F. Courtin
Hypoxia Stabilizes Type 2 Deiodinase Activity in Rat Astrocytes
Endocrinology, October 1, 2007; 148(10): 4745 - 4753.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Fekete, B. C. G. Freitas, A. Zeold, G. Wittmann, A. Kadar, Z. Liposits, M. A. Christoffolete, P. Singru, R. M. Lechan, A. C. Bianco, et al.
Expression Patterns of WSB-1 and USP-33 Underlie Cell-Specific Posttranslational Control of Type 2 Deiodinase in the Rat Brain
Endocrinology, October 1, 2007; 148(10): 4865 - 4874.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement